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Definition and Description 
For centuries before the beggining of 
scientific medicine, traditional medicine of 
various cultures around the world employed 
the use of medicinal plants as disease 
remedies. Products made from plants that 
are used to maintain or improve health have 
been called herbal medicines, remedies, 
supplements, botanicals or phytomedicines.1,2
Herbal Medicine may therefore be defined 
as:
Plant derived material or preparations 
with therapeutic health benefits, which 
contain either raw or processed ingredients 
from one or more plants(WHO 2005).3
Introduction
With limited regulatory oversight and strong 
advertising, many herbal products have made 
their way into pharmacies and health shops 
and into patients’ self-prescribed therapy. 
The internet has also become part of the 
marketplace. With the aim of moving away 
from the ‘synthetic’ world towards a more 
‘organic’ world, patients are increasingly 
seeking herbal remedies to self-treat medical 
conditions, complement conventional 
therapies, and maintain their overall health 
and well-being.2,4 
Most patients receive their information 
about herbs and supplements from 
sources other than their healthcare 
provider.2,4 Clinicians are often oblivious 
to their patients’ use of herbal medicines 
for a variety of reasons. Being natural 
products, patients wrongly believe they are 
always safe, others fear that healthcare 
professionals may have negative attitudes 
towards their use and do not report using 
such remedies to avoid confrontations. In 
addition, healthcare professionals are often 
not likely to ask patients about their self-
medication.2,4 
Negative effects can result from this 
lack of communication, which could include 
adverse effects or drug-herb interactions.1,4 
Patients may also substitute herbal remedies 
for more conventional therapies without 
informing their doctor.2 
Recently, most often unaware to 
both the healthcare professional and the 
patient, several dietary and multi-vitamin 
supplements began to introduce herbs into 
their preparations. Preparations for improved 
joint function, improved performance, hair 
and eye supplements, sleep aids, weight 
loss and advancing age are among the 
preparations which are including herbs. 
Hence, herbal medicines may also be 
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Educational Aims
•	 To	help	clear	the	‘myth’	that	herbal	medicines	are	entirely	safe	as	they	are	derived	from	
natural sources.
•	 To	provide	an	overview	of	the	different,	potential	types	of	drug-herb	interactions.
•	 To	highlight	the	importance	of	asking	patients	about	herbal	medicine	use	and	to	check	
for any possible interactions with their medications.
With the aim of moving away from the ‘synthetic’ world towards 
a more ‘organic’ world, patients are increasingly seeking herbal 
remedies to self-treat medical conditions. Most clinicians are oblivious 
to their patients’ use of herbal medicine. All medicinal agents have 
potentially unexpected effects including toxicity and interactions, 
and herbs are no different. Drug-herb interactions are based on the 
same pharmacokinetic and pharmacodynamic principles as drug-drug 
interactions. Herbal medicines do not need to be avoided, the only 
fundamental issue is that they should be considered as medicine 
and the adverse effects and potential interactions considered. Thus 
pharmacists and doctors should be better informed to minimise 
patient harm.
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consumed by those patients who did not 
specifically request their use.
Adverse effects and Interactions
All medicinal agents have potentially 
unexpected effects including toxicity, and 
herbs are no different.1,2,4-11 As with other 
drugs, the risk of unexpected effects may 
be influenced by a user’s age, gender, 
genetics, nutrition status, and concurrent 
disease states and treatments.2,4,9 In clinical 
practice recognizing adverse effects of herbal 
medicine is not routine and their reporting is 
even less frequent.2,4-9 
It is important to be aware of any 
substances that have the potential to cause 
toxicities and to interact with prescribed 
medications. Most adverse reactions involve 
the skin, liver, GI tract but can involve the 
heart (e.g.ephedra). Significant hepatotoxic 
effects were reported with kava or echinacea 
when taken concurrently with other 
heptatoxic drugs. The use of a drug and a 
herb that are both associated with potential 
hepatotoxic effects should be avoided.2 
Even less is known about interactions 
than about adverse effects and much is 
based on speculation or on theoretical 
interactions rather than evidence-based and 
many have only been observed in vitro and 
not in vivo (Table 2)5-9 It is important to 
note that in vitro effects are not necessarily 
replicated in vivo. Findings in vivo often 
appear weaker than those in vitro which 
would suggest that a clinical study is 
warranted.9
An interaction may involve having the 
herb component to cause an increase/ 
decrease in the amount of drug in the 
blood stream.5,6,9 Drug-herb interactions are 
based on the same pharmacokinetic and 
pharmacodynamic principles as drug-drug 
interactions.1,5,8,9
Pharmacokinetic Interactions
Absorption
Interactions affecting absorption result 
in a reduction/increase of the absorption 
of the drug.1-9 Changes in intestinal pH, 
complexing mechanisms and drugs affecting 
intestinal motility will affect absorption.5 For 
example, herbs such as aloe leaf, guar gum 
and senna, which are common ingredients in 
herbal weight-loss products, exert a laxative 
effect that may decrease intestinal transit 
time and reduce drug absorption. St. John’s 
Wort induces intestinal P-glycoprotein, 
which may decrease the absorption of 
common P-glycoprotein substrates, such as 
digoxin.5,6,8,9 Such effects may be reduced 
if the drug is consumed 1 hour before or 2 
hours after the herb.1
Distribution
A drug with high plasma protein binding 
(e.g. warfarin, carbamazepine) that has 
a small volume of distribution may be 
displaced by a herb competing for the 
same binding sites.1,5,6,8 Drug displacement 
from protein-bound forms, by concurrent 
drug administration, causes an increase in 
serum drug levels and which may lead to an 
increase in therapeutic effect.2,5,8
Metabolism
Enzyme Induction
A decrease in the amount of drug could occur 
by stimulating the production and activity of 
enzymes that degrade the drug and prepare 
it for elimination from the body.2,5,8,9 Such is 
the case with St.John’s Wort which induces 
the cytochrome P450 enzymes which are 
responsible for the metabolism of several 
drugs.1,2,4-11 This is a common mechanism 
and applies to the way in which St. John’s 
Wort may reduce the efficacy of the oral 
contraceptive pill or blood levels of warfarin, 
digoxin, protease inhibitors, theophylline, 
carbamazepine.4,5-11
Enzyme Inhibition
The opposite may also occur, in which the 
herb inhibits the production of the enzyme 
required to break down the drug, hence 
increasing the drug levels.5,8,9 Unlike enzyme 
induction, which may take several days or 
Table 1: Recommended Herbal Medicine References
National Center for Complementary and Alternative medicine. CAMCitationIndex. 
Available at: http://nccam.nih.gov/health/herbsataglance.htm
Literature citations (with abstracts) of all aspects of alternative medicine. Free.
NIH Office of Dietary Supplements. IBIS Database. Available at: http://ods.od.nih.
gov/
Literature citations (with abstracts) of dietary supplements including vitamins, minerals, 
and botanicals. Free.
Alternative Medicine Foundation, Inc. HerbMed. Available at: http://www.herbmed.
org/index.asp
Online monographs of 20 popular herbal products. Literature-based reviews with 
references. Free. Subscription required to view entire database (233 herbs).
Natural Medicines Comprehensive Database. Available on: http://www.nlm.nih.gov/
medlineplus/druginfo/natural/607.html
Provides online monographs of popular herbs. Free.
World Health Organisation, Geneva. 2011. Available on: http://apps.who.int/
medicinedocs/en/d/Js2200e/
Provides online monographs of 90 popular herbs. Free.
Baxter K, Driver S, Williamson E. Stockley’s herbal medicines interactions. 
London:Pharmaceutical Press;2009.
Literature-based review of more than 150 herbs with particular reference to their 
interaction profile. Online version available with subscription on MedicinesComplete 
(http://www.medicinescomplete.com)
Barnes J, Anderson LA, Phillipson JD. Herbal medicines: A guide for health care 
professionals. London: Pharmaceutical Press; 2007.
Herbal monographs. Literature-based reviews with references. Online version available with 
subscription on MedicinesComplete (http://www.medicinescomplete.com)
Fetrow CW, Avila JR. Professional’s handbook of complementary and alternative 
medicines. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2004.
Herbal monographs. Literature-based reviews with references.
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Table 2: Herb-Drug Interactions of particular concern
(N.B.This is not an exhaustive list. Many reactions are theoretical and have only been observed in vitro)1,4,5,6,9-15
Drug or Drug Class Herb(s) Effect
Anaesthetics Kava, Hawthorn, St John’s wort, Valerian
Excessive sedation, delayed emergence 
from anaesthesia
Opioid –analgesics
Valerian,
Ginseng, St. John’s wort
Additive CNS depression
Reduced analgesic effectiveness
Antidepressants St John’s wort, Gingko
May increase serotonin levels. May 
lead to serotonin syndrome with other 
serotonergic agents
Antidiabetic agents
Garlic,Ginseng,Milkthistle,Damiana,Eucalyptus, 
Fenugreek,St.John’s wort
Ephedra,Licorice
May cause hypoglycaemia
May cause hyperglycaemia
Anticonvulsants Gingko, Ephedra, Evening primrose oil
May increase risk of seizures, decrease 
drug effect
Antihypertensives
Ephedra, Devil’s Claw, Guarana (caffeine), Licorice, Ginseng
St. John’s wort 
May cause hypertension
Reduced effectiveness of some anti-
hypertensives
Benzodiazepines
Valerian, Kava, Hawthorn, Hops
St.John’s wort 
Excessive sedation
Reduced effectiveness
Corticosteriods
Echinacea (<8wks use), Licorice
Echinacea (>8wks use)
Immunostimulant effect of herb may 
offset immunosuppressant effect of 
corticosteroids.
May potentiate effect of 
immunosuppressant.
Immunosuppressants 
Echinacea, Licorice
St. John’s wort
Immunostimulant effect of herb may 
offset immunosuppressant effects.
May reduce immunosuppressant levels
Digoxin
Licorice, Cascara, Senna, Aloe, Cassia
Ginseng
St. John’s wort
May cause hypokalemia (patient more 
vulnerable to digoxin toxicity)
May cause falsely elevated digoxin 
levels
Decreases digoxin levels
Diuretics Ginseng, Licorice Decreases diuretic effects
Warfarin/anti-platelets/
anticoagulants
Feverfew, Ginger, Gingko, Garlic, Saw palmetto, Guarana, 
Passiflora, Cat’s claw, Cranberry, Evening primrose oil, 
Dandelion, Bilberry, Boldo
Ginseng, Green tea, St. John’s wort, Chamomile
May increase anticoagulant effects of 
warfarin
May decrease anticoagulant effect of 
warfarin
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HIV medication
Garlic, St John’s wort, Milkthistle, Gingko
Ginseng, Echinacea - use only short-term
May decrease protease inhibitor 
concentrations, increase risk of 
antiretroviral resistance
NSAIDS Garlic, Gingko, Feverfew Increased risk of bleeding
Laxatives Licorice, Senna, Cascara Increased risk of hypokalaemia
Oral Contraceptives
Licorice
Ginseng
Increased risk of fluid retention, 
hypertension
Additive estrogenic effects
Proton-pump inhibitors Cranberry, Gingko, St John’s wort Reduced effectiveness of PPIs
Antibiotics
Dandelion, Fennel
Cinnamon
St John’s wort
Decreased effectiveness of 
Fluoroquinolones
Decreased effectiveness of Tetracyclines
Increased risk of phototoxicity with 
tetracyclines
weeks to develop fully, enzyme inhibition 
can occur within 2-3 days resulting in a 
rapid development of toxicity.9 Licorice 
decreases the metabolism of corticosteroids, 
leading to adverse and toxic effects from the 
build-up of corticosteroids.1,9,11
Evidence obtained in vitro suggests 
that echinacea and chamomile may inhibit 
the cytochrome P450, isoenzyme CYP3A4. 
Concurrent use with drugs like alprazolam, 
simvastatin, calcium-channel blockers, and 
protease inhibitors could potentially increase 
serum drug levels and adverse effects.6-11
Excretion
Changes in excretion may also affect serum 
drug levels. Herbal diuretics are quite weak 
and unlikely to cause large problems.5 
However, chronic ingestion of licorice may 
result in hypokalemia and water retention 
and accordingly may interfere with various 
medications including antihypertensive and 
antiarrhythmic agents.7,8 
Pharmacodynamic Interactions
Additive interactions
A herb might produce the same kind of effect 
as the drug and give an increase in the drug 
effect (without increasing the amount of 
the drug).5,8,9 Therefore herbal sedatives, 
anticoagulants, antihypertensives and 
others may possibly increase the effect of a 
concurrent conventional drug taken for the 
same purpose. For example, the hyponotic 
activity of benzodiazepines is increased by 
valerian, and the anticoagulant action of 
warfarin is enhanced by gingko, garlic and 
ginger.1,5,8-11 
St John’s Wort together with other 
serotonergic drugs e.g. SSRIs may produce 
the additive effect of the serotonin syndrome 
characterised by altered mental status, 
autonomic dysfunction and neuromuscular 
abnormalities.9
Antagonistic interactions
A herb might produce an effect that is 
contrary to the effect desired for the drug, 
thereby reducing the drug effect.5,8,9 Ephedra 
or caffeine-containing herbs (cola nut, 
guarana, mate, green tea), often used in 
combination for the additive cardiovascular 
effects in many herbal weight-loss 
products, may antagonize the effects of 
antihypertensive medications.5,8
Conclusion
The fact that herbal medicines also have 
adverse effects and may give rise to 
potential drug-herb interactions does not 
imply that their use should be discouraged. 
Herbal medicines are not placebo and have 
been found to be efficacious,9-11 sometimes 
being a suitable alternative to conventional 
drugs. Most herbal drugs have good safety 
profiles however, the fact that they are often 
taken over a long period of time in various 
drug cocktails, may provide the opportunity 
for enzyme induction/inhibition to take 
place5. The only fundamental issue is that 
they should be considered as medicines 
and their adverse effects and potential 
interactions considered.2,4,5-9 Health care 
providers need to look closely at the risks 
and benefits of herbal medicines, just as 
they do with conventional medicine. 2,4,5-9 
In order that this may occur it is important 
that pharmacists and doctors should be 
better informed on herbal medicines.2,8,9-11 
Ideally more importance should be given 
in undergraduate course and Continuing 
Educational Programmes addressing herbal 
medicines should be offered to health 
professionals.2,4,8 
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Key points
•	 Pharmacists/doctors	must	take	the	initiative	in	creating	opportunities	to	discuss	
herbal medicines with patients.2,4
•	 Healthcare	professionals	must	be	aware	of	the	dietary/multivitamin	preparations	which	
contain herbal medicines. 
•	 Healthcare	professionals	must	have	access	to	reliable	reference	materials4,8-11 (Table 1) 
and utilise the Medicine Information Services at Mater Dei Hospital where a team of 
pharmacists are available to offer help on any enquiry including herbal/complementary 
medicine. (Contact number – 2545 6504).
•	 Pharmacists/doctors	must	be	on	the	alert	with	regards	to	drugs	having	a	narrow	
therapeutic window or where it is necessary to keep serum levels above a suitable 
level (e.g.anticoagulants, antidiabetic, antiepileptic, antihypertensive, anti-infective, 
immunosuppressants etc.)5,8,9
•	 Pharmacies	should	only	stock	herbals	from	reputable	manufacturers.2,4,5,9-11
•	 Hearbal	medicines	should	be	avoided	in	pregnancy/lactation	and	used	with	caution	in	
patients with reduced liver/renal function.9-11
•	 The	stated	dosage	and	duration	of	dosage	should	be	adhered	to.4,9-11
•	 Patients	should	be	advised	to	be	alert	to	possible	adverse	effects	and	interactions	with	
lab results.2,4,9-11
•	 Herbal	medicines	should	be	stopped	at	least	7	days	before	surgery.9
•	 Patients	should	be	advised	not	to	take	herbal	medicines	and	conventional	medications	
together or at the same time.4,8,9
Levitra® film-coated tablets and Levitra® orodispersible 
tablets (vardenafil) Prescribing Information (Refer to 
full Summary of product Characteristics (SmPC) before 
prescribing)
Presentation: Levitra® film-coated tablets: 5/10/20mg 
vardenafil (as hydrochloride trihydrate). Levitra® 
orodispersible tablets: 10mg (as hydrochloride). Indication: 
Treatment of erectile dysfunction. To be effective, 
sexual stimulation is required. Posology and method 
of administration: Film-coated: 10mg approximately
25–60 minutes before sexual activity. Based on efficacy and 
tolerability, dose may be increased to 20mg or decreased 
to 5mg. Maximum dose is 20mg/day.Can be taken with or 
without food. Onset of activity may be delayed if taken with 
a high fat meal. Orodispersible: 10mg approximately 60 
minutes before sexual activity. Maximum dose is 10mg/day. 
It can be taken with or without food, but not with liquid. Elderly 
men: no dosage adjustment required, though increase to a 
maximum 20mg film-coated tablets dose should be carefully 
considered depending on individual tolerability. Children and 
adolescents: not indicated for individuals <18 years of age. 
Hepatic and renal impairment: Consider starting with 5mg 
film-coated tablets in patients with mild-moderate hepatic 
impairment or severe renal impairment. Orodispersible 
tablets should not be used in patients with moderate to 
severe hepatic impairment or with end-stage renal failure. 
Use with other medicinal products:  In combination with 
CYP 3A4 inhibitors, the dose should not exceed 5mg 
film-coated tablets. Contra- indications: Hypersensitivity 
to vardenafil or to any excipients; co administration with 
Levitra® before driving or operating machinery. Undesirable 
Effects: Very common: flushing (film-coated tablets only) 
and headache. Common: nausea (film-coated tablets 
only), dizziness, nasal congestion, and dyspepsia. Serious 
side effects: cf. CI/ Warnings and Precautions-in addition: 
tachycardia, palpitations, angina pectoris, myocardial 
infarction, seizure, priapism, NAION, visual defect, 
laryngeal oedema, increased intraocular pressure, and 
sudden deafness. Serious cardiovascular events, including 
cerebrovascular haemorrhage, sudden cardiac death, 
transient ischaemic attack, unstable angina and ventricular 
arrhythmia reported post marketing in temporal association 
with another medicinal product in the same class. In addition, 
myocardial ischaemia and laryngeal oedema (film-coated 
tablets only) and paraesthesia/dysaesthesia, ventricular 
tachyarrhythmias and chest pain (orodispersible tablets only). 
Prescribers should consult the SmPC in relation to other side 
effects. Overdose: an increase in undesirable effects may 
be observed. Legal Category: POM. Package Quantities: 
Film-coated: 4x5mg, , 4x 10mg, 4x20mg. Orodispersible: 
4x10mg. MA Number(s): EU/1/03/248/001-015. Further in 
formation available from: Bayer Health Care; c/o Alfred Gera 
& Sons Ltd, Triq il-Masgar Qormi, Malta. Tel. +356 21446205.
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